GE HealthCare Technologies
$63.98Change from previous close: −2.13%Absolute change: −$1.39
Valuation
Data as of October 2, 2026
Valuation multiples
- Market cap
- $29.1B
- Enterprise value
- $37.6B
- P/E (trailing 12 months)
- 15.1
- Forward P/E
- 11.8
- PEG
- 1.63
- Price/book
- 2.63
- Price/sales
- 1.37
- EV/EBITDA
- 10.5
- EV/revenue
- 1.77
Profitability and growth
- Gross margin
- 39.5%
- Operating margin
- 15.0%
- Net margin
- 9.3%
- ROE
- 19.4%
- ROA
- 5.1%
- Revenue growth (year over year)
- 5.8%
- Earnings growth (year over year)
- 16.8%
Financial health
- Total cash
- $2.08B
- Total debt
- $10.54B
- Debt/equity
- 0.94
- Current ratio
- 1.26
- Quick ratio
- 0.83
Dividends
- Annual dividend per share
- $0.16
- Dividend yield
- 0.2%
- Payout ratio
- 3.2%
- Ex-dividend date
- October 23, 2026
Analysts and estimates
- Average price target
- $83.05
- Median price target
- $84.00
- High price target
- $96.00
- Low price target
- $70.00
- Analysts with a price target
- 19
- Consensus
- Buy
- Forward EPS
- $5.41
- EPS estimate, current year
- $4.93
Shares and trading
- Beta
- 0.82
- Average volume
- 4.11M
- Shares outstanding
- 454.89M
- Float
- 450.2M
- Institutional ownership
- 94.0%
- Insider ownership
- 0.4%
- Short interest (% of float)
- 4.2%
- Short ratio (days)
- 6.01